Krishna Undela

Employment

• National Institute of Pharmaceutical Education and Research Assistant Professor
  2020 - Present
• JSS College of Pharmacy Lecturer
  2012 - 2020

Education

• National Institute of Pharmaceutical Education and Research M.Pharm
  2010 - 2012
• Sree Vidyanikethan College of Pharmacy B.Pharm
  2007 - 2010

Projects & Funding

Projects & funding information is unavailable.

Publications (40)

• Gallbladder Cancer Risk Factors in Northeast India: A Mixed-method Integration of Population Attributable Fractions With Global Evidence
  Journal of Clinical and Experimental Hepatology 2026 DOI: 10.1016/j.jceh.2026.103470
  +Save
• Injection‐site and dermatologic reactions associated with glucagon‐like peptide‐1 receptor agonists: Insights from meta‐analysis of randomised controlled trials and real‐world evidence
  Diabetes, Obesity and Metabolism 2026 DOI: 10.1111/dom.70382
  +Save
• Safety of immune checkpoint inhibitors: A systematic review of disproportionality analysis studies
  European Journal of Clinical Pharmacology 2026 DOI: 10.1007/s00228-025-03960-1
  +Save
• Geriatric syndromes, comorbidities, and polypharmacy: Determinants of health-related quality of life in hospitalized older adults in South India
  Geriatric Nursing 2026 DOI: 10.1016/j.gerinurse.2026.103950
  +Save
• Identifying potential drug triggers for bullous pemphigoid: a disproportionality analysis of the FDA adverse event reporting system and systematic review of case reports
  Cutaneous and Ocular Toxicology 2025 DOI: 10.1080/15569527.2025.2554799
  +Save
• Efficacy and safety of capecitabine therapy in patients with Biliary tract cancer: A systematic review and meta-analysis
  Journal of Oncology Pharmacy Practice 2025 DOI: 10.1177/10781552251372874
  +Save
• Signal detection of ferric carboxymaltose-induced serious adverse events: disproportionality analysis of FAERS and VigiBase data and systematic review of case reports
  European Journal of Clinical Pharmacology 2025 DOI: 10.1007/s00228-025-03849-z
  +Save
• Risk of serious skin and subcutaneous tissue disorders for nimesulide among the pediatric population: a jeopardy identified through the analysis of global individual case safety reports
  Expert Opinion on Drug Safety 2024 DOI: 10.1080/14740338.2023.2274416
  +Save
• Efficacy and safety of luseogliflozin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
  Endocrine 2024 DOI: 10.1007/s12020-024-03925-x
  +Save
• Assessment of disease pattern and drug utilization among neurology intensive care unit patients in a developing country: an observational analysis
  Hospital Practice 2024 DOI: 10.1080/21548331.2024.2358747
  +Save